Dawn DiGiugno Parker

Title: Dawn DiGiugno Parker: Innovator in Pharmaceutical Advancements

Introduction: Dawn DiGiugno Parker is a notable inventor based in Guilford, Connecticut, specializing in pharmaceutical innovations. With a unique approach to drug formulation, she has made significant contributions to the field, reflecting her dedication to advancing medical treatments.

Latest Patents: Dawn holds a patent for her invention related to crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine and its salts and solvates. This patent outlines not only the crystalline forms but also pharmaceutical compositions comprising these forms. Additionally, it includes methods for their use in treating HIV and AIDS, along with techniques for obtaining these crystalline forms.

Career Highlights: Dawn is currently associated with Bristol-Myers Squibb Company, a leading biopharmaceutical firm known for its cutting-edge research and innovative therapies. Her role has allowed her to contribute to the development of new treatments that have the potential to improve patient care and health outcomes.

Collaborations: Throughout her career, Dawn has collaborated with esteemed colleagues such as Chung-Pin H Chen and Qi Gao. These partnerships highlight the collaborative spirit within the pharmaceutical research community, emphasizing the importance of teamwork in achieving innovative breakthroughs.

Conclusion: Dawn DiGiugno Parker exemplifies the essence of innovation in the pharmaceutical industry. Her patent and contributions reflect a commitment to enhancing treatment options for serious illnesses like HIV and AIDS. As she continues her work at Bristol-Myers Squibb Company, her impact on medical science and patient health remains significant.